Overview

Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients

Status:
Recruiting
Trial end date:
2023-02-22
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of CertiroBell® tablet plus tacrolimus
Phase:
Phase 4
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Everolimus